Literature DB >> 24184028

The CURE-AF trial: a prospective, multicenter trial of irrigated radiofrequency ablation for the treatment of persistent atrial fibrillation during concomitant cardiac surgery.

Ralph J Damiano1, Vinay Badhwar2, Michael A Acker3, Ramesh S Veeragandham4, David C Kress5, Jason O Robertson6, Thoralf M Sundt7.   

Abstract

BACKGROUND: Ablation technology has been introduced to replace the surgical incisions of the Cox-Maze procedure in order to simplify the operation. However, the efficacy of these ablation devices has not been prospectively evaluated.
OBJECTIVE: The purpose of this study was to examine the efficacy and safety of irrigated unipolar and bipolar radiofrequency ablation for the treatment of persistent and long-standing persistent atrial fibrillation (AF) during concomitant cardiac surgical procedures.
METHODS: Between May 2007 and July 2011, 150 consecutive patients were enrolled at 15 U.S. centers. Patients were followed for 6 to 9 months, at which time a 24-hour Holter recording and echocardiogram were obtained. Recurrent AF was defined as any atrial tachyarrhythmia (ATA) lasting over 30 seconds on the Holter monitor. The safety end-point was the percent of patients who suffered a major adverse event within 30 days of surgery. All patients underwent a biatrial Cox-Maze lesion set.
RESULTS: Operative mortality was 4%, and there were 4 (3%) 30-day major adverse events. Overall freedom from ATAs was 66%, with 53% of patients free from ATAs and also off antiarrhythmic drugs at 6 to 9 months. Increased left atrial diameter, shorter total ablation time, and an increasing number of concomitant procedures were associated with recurrent AF (P <.05).
CONCLUSION: Irrigated radiofrequency ablation for treatment of AF during cardiac surgery was associated with a low complication rate. No device-related complications occurred. The Cox-Maze lesion set was effective at restoring sinus rhythm and had higher success rates in patients with smaller left atrial diameters and longer ablation times.
© 2013 Heart Rhythm Society Published by Heart Rhythm Society All rights reserved.

Entities:  

Keywords:  AF; ATA; AV; Arrhythmia surgery; Atrial fibrillation; CS; CURE-AF; Concomitant Utilization of Radiofrequency Energy for Atrial Fibrillation; FDA; Food and Drug Administration; IDE; LA; LAA; LVEF; MAE; MI; MV; MVA; Maze procedure; NYHA; New York Heart Association; PV; PVI; RA; RF; Radiofrequency ablation; SVC; Surgical ablation; atrial fibrillation; atrial tachyarrhythmia; atrioventricular; coronary sinus; investigational device exemption; left atrial appendage; left atrium; left ventricular ejection fraction; major adverse event; mitral valve; mitral valve annulus; myocardial infarction; pulmonary vein; pulmonary vein isolation; radiofrequency; right atrium; superior vena cava

Mesh:

Year:  2013        PMID: 24184028     DOI: 10.1016/j.hrthm.2013.10.004

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  11 in total

1.  Surgical ablation is effective: But surgeons need to do better.

Authors:  Robert B Hawkins; Gorav Ailawadi
Journal:  J Thorac Cardiovasc Surg       Date:  2015-08-15       Impact factor: 5.209

2.  Late outcomes after the Cox maze IV procedure for atrial fibrillation.

Authors:  Matthew C Henn; Timothy S Lancaster; Jacob R Miller; Laurie A Sinn; Richard B Schuessler; Marc R Moon; Spencer J Melby; Hersh S Maniar; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2015-08-08       Impact factor: 5.209

3.  Surgical outcomes of modified-maze procedures in adults with atrial septal defect.

Authors:  Shun-Ichiro Sakamoto; Atsushi Hiromoto; Yosuke Ishii; Takashi Sasaki; Yasuo Miyagi; Takashi Nitta
Journal:  Surg Today       Date:  2018-09-03       Impact factor: 2.549

4.  Right minithoracotomy versus conventional median sternotomy for patients undergoing mitral valve surgery and Cox-maze IV ablation with entirely bipolar radiofrequency clamp.

Authors:  Zhaolei Jiang; Min Tang; Nan Ma; Hao Liu; Fangbao Ding; Chunrong Bao; Ju Mei
Journal:  Heart Vessels       Date:  2018-02-02       Impact factor: 2.037

Review 5.  Destruction Of Medium Already Afected By Destructive Disorder: Fibrillating Atria Conceptually Need Therapeutic Help Rather Than Surgical Or Ablative Destruction.

Authors:  Petras Stirbys
Journal:  J Atr Fibrillation       Date:  2014-06-30

6.  Sinus Rhythm Restoration after Radiofrequency Ablation Improves Survival in Patients Undergoing Mitral Valve Surgery : A Eight Year Single Center Study.

Authors:  Carlo Rostagno; Irene Capecchi; Sandro Gelsomino; Enrico Carone; Pier Luigi Stefàno
Journal:  J Atr Fibrillation       Date:  2017-06-30

7.  Barriers to atrial fibrillation ablation during mitral valve surgery.

Authors:  J Hunter Mehaffey; Eric J Charles; Michaela Berens; Melissa J Clark; Chris Bond; Clifford E Fonner; Irving Kron; Annetine C Gelijns; Marissa A Miller; Eric Sarin; Matthew Romano; Richard Prager; Vinay Badhwar; Gorav Ailawadi
Journal:  J Thorac Cardiovasc Surg       Date:  2021-03-17       Impact factor: 6.439

8.  Long-term efficacy of surgical ablation of atrial fibrillation in a low-volume centre.

Authors:  Maciej Rachwalik; Dorota Zyśko; Grzegorz Bielicki; Marta Obremska; Anna Goździk; Wojciech Kustrzycki
Journal:  Kardiochir Torakochirurgia Pol       Date:  2015-12-30

9.  Intraoperative Inducibility of Atrial Fibrillation Does Not Predict Early Postoperative Atrial Fibrillation.

Authors:  Eva A H Lanters; Christophe P Teuwen; Ameeta Yaksh; Charles Kik; Lisette J M E van der Does; Elisabeth M J P Mouws; Paul Knops; Nicole J van Groningen; Thijmen Hokken; Ad J J C Bogers; Natasja M S de Groot
Journal:  J Am Heart Assoc       Date:  2018-03-10       Impact factor: 5.501

10.  The long-term efficacy of concomitant maze IV surgery in patients with atrial fibrillation.

Authors:  Camilla Skals Engelsgaard; Kenneth Bruun Pedersen; Lars Peter Riber; Peter Appel Pallesen; Axel Brandes
Journal:  Int J Cardiol Heart Vasc       Date:  2018-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.